Search research articles
Contact Us
Filters
Showing results (611-620 of 686) with videos related to
Page
of 69
Sort By:
The International Journal of Cardiovascular Imaging
|
September 5, 2008
Demonstration of left ventricular outflow tract eccentricity by 64-slice multi-detector CT
Sanjay Doddamani, Michael J Grushko, Amgad N Makaryus, et al.
AJNR. American Journal of Neuroradiology
|
February 2, 2019
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in <i>IDH</i>-Mutant Lower Grade Gliomas
P P Batchala, T J E Muttikkal, J H Donahue, et al.
European Journal of Pharmacology
|
April 20, 2022
ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models
Mukul R Jain, Rakesh B Patel, Kanaiyalal D Prajapati, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 3, 2017
Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia
Harilal Patel, Amit Arvind Joharapurkar, Vrajesh Bhaskarbhai Pandya, et al.
European Journal of Medicinal Chemistry
|
July 6, 2007
Synthesis and in vitro antibacterial activities of novel oxazolidinones
Brijesh Kumar Srivastava, Mukul R Jain, Manish Solanki, et al.
Scientific Reports
|
June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Indian Journal of Pharmacology
|
April 17, 2015
Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: possible role of tissue inhibitor of metalloproteinase-3
Jignesh K Nagar, Praful P Patel, Jogeswar N Mohapatra, et al.
Journal of Diabetes
|
October 21, 2014
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitor
Mukul R Jain, Amit A Joharapurkar, Rajesh H Bahekar, et al.
Journal of Digestive Diseases
|
May 28, 2021
Quantifying the rate of recurrence of postoperative Crohn's disease with biological therapy. A meta-analysis
Sneha R Jain, Zachariah G W Ow, Yip H Chin, et al.
Drug Research
|
February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent Model
Harilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
Page
of 69
Search research articles
Search
Showing results (611-620 of 686) with videos related to
Sort By:
Page
of 69
The International Journal of Cardiovascular Imaging
|
September 5, 2008
Demonstration of left ventricular outflow tract eccentricity by 64-slice multi-detector CT
Sanjay Doddamani, Michael J Grushko, Amgad N Makaryus, et al.
AJNR. American Journal of Neuroradiology
|
February 2, 2019
Neuroimaging-Based Classification Algorithm for Predicting 1p/19q-Codeletion Status in <i>IDH</i>-Mutant Lower Grade Gliomas
P P Batchala, T J E Muttikkal, J H Donahue, et al.
European Journal of Pharmacology
|
April 20, 2022
ZYKR1, a novel, potent, and peripherally selective kappa opioid receptor agonist reduces visceral pain and pruritus in animal models
Mukul R Jain, Rakesh B Patel, Kanaiyalal D Prajapati, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems
|
January 3, 2017
Influence of acute and chronic kidney failure in rats on the disposition and pharmacokinetics of ZYAN1, a novel prolyl hydroxylase inhibitor, for the treatment of chronic kidney disease-induced anemia
Harilal Patel, Amit Arvind Joharapurkar, Vrajesh Bhaskarbhai Pandya, et al.
European Journal of Medicinal Chemistry
|
July 6, 2007
Synthesis and in vitro antibacterial activities of novel oxazolidinones
Brijesh Kumar Srivastava, Mukul R Jain, Manish Solanki, et al.
Scientific Reports
|
June 11, 2020
The PPAR α/γ Agonist Saroglitazar Improves Insulin Resistance and Steatohepatitis in a Diet Induced Animal Model of Nonalcoholic Fatty Liver Disease
Divya P Kumar, Rebecca Caffrey, Jonathon Marioneaux, et al.
Indian Journal of Pharmacology
|
April 17, 2015
Differential effects of dexamethasone and rosiglitazone in a sephadex-induced model of lung inflammation in rats: possible role of tissue inhibitor of metalloproteinase-3
Jignesh K Nagar, Praful P Patel, Jogeswar N Mohapatra, et al.
Journal of Diabetes
|
October 21, 2014
Pharmacological characterization of ZYDPLA1, a novel long-acting dipeptidyl peptidase-4 inhibitor
Mukul R Jain, Amit A Joharapurkar, Rajesh H Bahekar, et al.
Journal of Digestive Diseases
|
May 28, 2021
Quantifying the rate of recurrence of postoperative Crohn's disease with biological therapy. A meta-analysis
Sneha R Jain, Zachariah G W Ow, Yip H Chin, et al.
Drug Research
|
February 4, 2017
Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent Model
Harilal Patel, Amit A Joharapurkar, Rajesh Bahekar, et al.
Page
of 69